PCV46 Assessing the Cost-Effectiveness of the Recommended Antihypertensive Drug Classes in France Using a Lifetime Markov Model
Value in Health - United Kingdom
doi 10.1016/j.jval.2012.03.649
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2012
Authors
Publisher
Elsevier BV